ReviewReviews in endocrine & metabolic disorders2026

Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors.

Pedro Carrera-Bastos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.